Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$137.51 - $190.8 $921,179 - $1.28 Million
-6,699 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$164.63 - $211.93 $1.1 Million - $1.42 Million
6,699 New
6,699 $1.17 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.